Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
Giaquinto AN, Sung H, Miller KD, et al. Breast Cancer Statistics, 2022. CA Cancer J Clin. 2022;72(6):524–41. https://doi.org/10.3322/caac.21754.
Yi M, Li T, Niu M, Luo S, Chu Q, Wu K. Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study. Biomark Res. 2021;9(1):55. https://doi.org/10.1186/s40364-021-00310-y.
Article PubMed PubMed Central Google Scholar
Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75. https://doi.org/10.1016/s0140-6736(17)33326-3.
Article PubMed PubMed Central Google Scholar
Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond). 2021;41(10):1037–48. https://doi.org/10.1002/cac2.12197.
Trapani D, Ginsburg O, Fadelu T, et al. Global challenges and policy solutions in breast cancer control. Cancer Treat Rev. 2022;104:102339. https://doi.org/10.1016/j.ctrv.2022.102339.
Kedar DJ, Yanko R, Barnea Y, Inbal A, Fliss E, Zaretski A. Breast cancer-related lymphedema: incidence and risk factors, preventive measures and treatments. Harefuah. 2022;161(2):115–20.
Shih YC, Xu Y, Cormier JN, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009;27(12):2007–14. https://doi.org/10.1200/jco.2008.18.3517.
Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg. 2018;7(4):379–403. https://doi.org/10.21037/gs.2017.11.04s.
Article PubMed PubMed Central Google Scholar
McLaughlin SA, Brunelle CL, Taghian A. Breast cancer-related lymphedema: risk factors, screening, management, and the impact of locoregional treatment. J Clin Oncol. 2020;38(20):2341–50. https://doi.org/10.1200/jco.19.02896.
Article PubMed PubMed Central Google Scholar
Johnson AR, Kimball S, Epstein S, et al. Lymphedema incidence after axillary lymph node dissection: quantifying the impact of radiation and the lymphatic microsurgical preventive healing approach. Ann Plast Surg. 2019;82(4S Suppl 3):S234–s241. https://doi.org/10.1097/sap.0000000000001864.
Article CAS PubMed Google Scholar
Lee KT, Bang SI, Pyon JK, Hwang JH, Mun GH. Method of breast reconstruction and the development of lymphoedema. Br J Surg. 2017;104(3):230–7. https://doi.org/10.1002/bjs.10397.
Shen A, Lu Q, Fu X, et al. Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies. Support Care Cancer. 2022;31(1):18. https://doi.org/10.1007/s00520-022-07508-2.
Shah C, Arthur D, Riutta J, Whitworth P, Vicini FA. Breast-cancer related lymphedema: a review of procedure-specific incidence rates, clinical assessment AIDS, treatment paradigms, and risk reduction. Breast J. 2012;18(4):357–61. https://doi.org/10.1111/j.1524-4741.2012.01252.x.
Macadam SA, Zhong T, Weichman K, et al. Quality of life and patient-reported outcomes in breast cancer survivors: a multicenter comparison of four abdominally based autologous reconstruction methods. Plast Reconstr Surg. 2016;137(3):758–71. https://doi.org/10.1097/01.prs.0000479932.11170.8f.
Article CAS PubMed PubMed Central Google Scholar
Fu MR, Ridner SH, Hu SH, Stewart BR, Cormier JN, Armer JM. Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011. Psychooncology. 2013;22(7):1466–84. https://doi.org/10.1002/pon.3201.
Cheng MH, Ho OA, Tsai TJ, Lin YL, Kuo CF. Breast cancer-related lymphedema correlated with incidence of cellulitis and mortality. J Surg Oncol. 2022;126(7):1162–8. https://doi.org/10.1002/jso.27054.
Article CAS PubMed Google Scholar
• Jørgensen MG, Hermann AP, Madsen AR, et al. Cellulitis is associated with severe breast cancer-related lymphedema: an observational study of tissue composition. Cancers (Basel). 2021;13(14) https://doi.org/10.3390/cancers13143584s. This study on 206 unilateral Breast Cancer-Related Lymphedema patients finds that cellulitis is linked to increased fat and lean mass in the affected limb, with patient BMI affecting fat mass distribution.
• Engin O, Sahin E, Saribay E, Dilek B, Akalin E. Risk factors for developing upper limb cellulitis after breast cancer treatment. Lymphology. 2022;55(2):77–83. This research on 523 breast cancer patients found that bigger limb sizes, longer lymphedema, and less education raise the risk of cellulitis. Main factors are lymphedema, its duration, radiotherapy, and education. Managing lymphedema early is key to avoid cellulitis.
Slaghmuylder Y, Pype P, Van Hecke A, Lauwerier E. Development of an intervention aimed at the prevention and treatment of chronic pain in breast cancer survivors: an intervention mapping approach. Patient Educ Couns. 2023;108:107618. https://doi.org/10.1016/j.pec.2022.107618.
McEvoy MP, Ravetch E, Patel G, Fox J, Feldman S. Prevention of breast cancer-related lymphedema. Clin Breast Cancer. 2021;21(2):128–42. https://doi.org/10.1016/j.clbc.2021.02.009.
DeSnyder SM, Yi M, Boccardo F, et al. American Society of Breast Surgeons’ practice patterns for patients at risk and affected by breast cancer-related lymphedema. Ann Surg Oncol. 2021;28(10):5742–51. https://doi.org/10.1245/s10434-021-10494-0.
Shah C, Arthur DW, Wazer D, Khan A, Ridner S, Vicini F. The impact of early detection and intervention of breast cancer-related lymphedema: a systematic review. Cancer Med. 2016;5(6):1154–62. https://doi.org/10.1002/cam4.691.
Article PubMed PubMed Central Google Scholar
Shah C, Zambelli-Weiner A, Delgado N, Sier A, Bauserman R, Nelms J. The impact of monitoring techniques on progression to chronic breast cancer-related lymphedema: a meta-analysis comparing bioimpedance spectroscopy versus circumferential measurements. Breast Cancer Res Treat. 2021;185(3):709–40. https://doi.org/10.1007/s10549-020-05988-6.
Zasadzka E, Trzmiel T, Kleczewska M, Pawlaczyk M. Comparison of the effectiveness of complex decongestive therapy and compression bandaging as a method of treatment of lymphedema in the elderly. Clin Interv Aging. 2018;13:929–34. https://doi.org/10.2147/cia.S159380.
Article PubMed PubMed Central Google Scholar
Bergmann A, Baiocchi JMT, de Andrade MFC. Conservative treatment of lymphedema: the state of the art. J Vasc Bras. 2021;20:e20200091. https://doi.org/10.1590/1677-5449.200091.
Article PubMed PubMed Central Google Scholar
Dean LT, Moss SL, Ransome Y, et al. “It still affects our economic situation”: long-term economic burden of breast cancer and lymphedema. Support Care Cancer. 2019;27(5):1697–708. https://doi.org/10.1007/s00520-018-4418-4.
Dean LT, Ransome Y, Frasso-Jaramillo L, et al. Drivers of cost differences between US breast cancer survivors with or without lymphedema. J Cancer Surviv. 2019;13(5):804–14. https://doi.org/10.1007/s11764-019-00799-1.
Article PubMed PubMed Central Google Scholar
Basta MN, Fox JP, Kanchwala SK, et al. Complicated breast cancer-related lymphedema: evaluating health care resource utilization and associated costs of management. Am J Surg. 2016;211(1):133–41. https://doi.org/10.1016/j.amjsurg.2015.06.015.
Omidi Z, Kheirkhah M, Abolghasemi J, Haghighat S. Effect of lymphedema self-management group-based education compared with social network-based education on quality of life and fear of cancer recurrence in women with breast cancer: a randomized controlled clinical trial. Qual Life Res. 2020;29(7):1789–800. https://doi.org/10.1007/s11136-020-02455-z.
Article PubMed PubMed Central Google Scholar
Shaitelman SF, Chiang YJ, Griffin KD, et al. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Res Treat. 2017;162(2):201–15. https://doi.org/10.1007/s10549-016-4089-0.
Article CAS PubMed Google Scholar
Naoum GE, Roberts S, Brunelle CL, et al. Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial. J Clin Oncol. 2020;38(29):3430–8. https://doi.org/10.1200/jco.20.00459.
Article PubMed PubMed Central Google Scholar
Noguchi M, Inokuchi M, Noguchi M, Morioka E, Ohno Y, Kurita T. Axillary surgery for breast cancer: past, present, and future. Breast Cancer. 2021;28(1):9–15. https://doi.org/10.1007/s12282-020-01120-0.
Galimberti V, Cole BF, Viale G, et al. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial. Lancet Oncol. 2018;19(10):1385–93. https://doi.org/10.1016/s1470-2045(18)30380-2.
Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) Randomized Clinical Trial. Jama. 2017;318(10):918–26. https://doi.org/10.1001/jama.2017.11470.
Comments (0)